EPGL e mail this morning -
EP Global Communications, Inc.
Website Click here
We like EPGL the company.. ALOT. And If your in this for some quick easy looking returns short term, your going to love the technicals, (Charts Below) But first.. Make sure you take a good hard look at exactly what this Debt Free Company is all about and why EPGL has been cleared for Take OFF!
EPGL is focused on developing and marketing medical devices for both diagnosis and treatment of chronic pain. EPGL Med’s first medical device, the MPDD, will be released in 2013 to awaiting physicians worldwide.
The FDA cleared MPDD medical device can help physicians detect the exact point of pain origination in muscles as never before. EPGL is currently working to invent and develop additional cutting edge medical device technology products to introduce subsequently to the MPDD, including biomedical devices which utilize Bio-Micro-Electro Mechanical Systems technology (Bio-MEMS).
Bio-MEMS is one of the fastest growing and promising new frontiers in medical technology today with possibilities in both medical diagnostic and treatment applications.
Products for Physicians
MPDD – Revolutionary Pain Management Device – FDA 510k Cleared
Americans spend over $85 billion dollars annually on treatment for chronic back pain. Much of this money is wasted on failed surgeries and misdiagnosis. In fact, the medical industry has a term for this; “FBSS” or Failed Back Surgery Syndrome. Medicare is charged billions of dollars annually for these failures. Both Physicians and Medicare are desperately in need of a better diagnosis tool for chronic back pain and muscular pain.
The MPDD device is a developed clinical and technological platform that promises to greatly increase the accuracy with which muscle pain is diagnosed and drive down health care costs associated with chronic pain. EPGL Med has set forth to capitalized on an opportunity to work with leading pain management physicians, on marketing a medical device to facilitate a revolutionary method for pain diagnosis. The MPDD has received FDA 510K clearance for marketing and manufacture.
__________________________________________________________
Key points You Must Know Before the Opening Bell
1. Tight Float.. Very. The Rest are restricted shares.
2. Debt free
3. Pricewaterhouse Coopers Manages Major Equity Position, 1/2 (the only penny stock they fully commited that we know of)
4. David T. Markus PhD. runs development and is world leading BioMEMS engineer
5. Major Conference Calls Series concluding Tuesday April 30th, announced new technology called "Topspin" for development of BioMEMS medical devices. Bringing "smart" technology
6. EPGL's BioMems technology and know-how exceeds other $50 billion dollar medical device companies like Medtronics or St. Jude. In fact EPGL has former Medtronic people on the team in addition to David T. Markus PhD.
7. EPGL aims to pioneer and own the "smart medical device" market. Will integrate Google Glass technology.
9. Exclusive rights to a new FDA 510k cleared medical device called the Muscle Pain Detection Device.
8. EPGL is extremely undervalued and with the significant technology value they possess should put them into the $8.00 range near term. More than $80.00 long term.
I`ll Leave it at that.. For Now.
Make sure you get started on your research
EPGL Website Click here
___________________________________________________________
EPGL: Technical Guidance
EPGL Made a HUGE Move back in early January 2013 And Traders have been taking full advantage of the swings ever since.
Don`t worry if you missed any of swings because it looks like we are about to
catch the biggest swing of them all.. Be Ready.
See for yourself: 6 Month Chart Click here
RSI is just under .50 and MACD is just a few trades away from a bullish cross
with plenty of room to the upside to take out the 52 week highs for good.
Make sure your in position before it happens!
Also, EPGL just filled the gap on a bounce off rock solid support which is exactly what traders have been waiting for before they get ready to go BIG.
It`s ok to go big as long as you keep those losses small, make sure your in
early and enter at or near support and resistance.
Take a closer look: EPGL 3 Month Click here
If any of our alerts fall below a % your not comfortable with..
Exit the trade and re-enter on support using the charts we provide.
That`s it.. for now.
Bookmark The Charts.. Trade Smart.. We will keep you
updated along the way.
EP Global Communications, Inc.
Website Click here
We like EPGL the company.. ALOT. And If your in this for some quick easy looking returns short term, your going to love the technicals, (Charts Below) But first.. Make sure you take a good hard look at exactly what this Debt Free Company is all about and why EPGL has been cleared for Take OFF!
EPGL is focused on developing and marketing medical devices for both diagnosis and treatment of chronic pain. EPGL Med’s first medical device, the MPDD, will be released in 2013 to awaiting physicians worldwide.
The FDA cleared MPDD medical device can help physicians detect the exact point of pain origination in muscles as never before. EPGL is currently working to invent and develop additional cutting edge medical device technology products to introduce subsequently to the MPDD, including biomedical devices which utilize Bio-Micro-Electro Mechanical Systems technology (Bio-MEMS).
Bio-MEMS is one of the fastest growing and promising new frontiers in medical technology today with possibilities in both medical diagnostic and treatment applications.
Products for Physicians
MPDD – Revolutionary Pain Management Device – FDA 510k Cleared
Americans spend over $85 billion dollars annually on treatment for chronic back pain. Much of this money is wasted on failed surgeries and misdiagnosis. In fact, the medical industry has a term for this; “FBSS” or Failed Back Surgery Syndrome. Medicare is charged billions of dollars annually for these failures. Both Physicians and Medicare are desperately in need of a better diagnosis tool for chronic back pain and muscular pain.
The MPDD device is a developed clinical and technological platform that promises to greatly increase the accuracy with which muscle pain is diagnosed and drive down health care costs associated with chronic pain. EPGL Med has set forth to capitalized on an opportunity to work with leading pain management physicians, on marketing a medical device to facilitate a revolutionary method for pain diagnosis. The MPDD has received FDA 510K clearance for marketing and manufacture.
__________________________________________________________
Key points You Must Know Before the Opening Bell
1. Tight Float.. Very. The Rest are restricted shares.
2. Debt free
3. Pricewaterhouse Coopers Manages Major Equity Position, 1/2 (the only penny stock they fully commited that we know of)
4. David T. Markus PhD. runs development and is world leading BioMEMS engineer
5. Major Conference Calls Series concluding Tuesday April 30th, announced new technology called "Topspin" for development of BioMEMS medical devices. Bringing "smart" technology
6. EPGL's BioMems technology and know-how exceeds other $50 billion dollar medical device companies like Medtronics or St. Jude. In fact EPGL has former Medtronic people on the team in addition to David T. Markus PhD.
7. EPGL aims to pioneer and own the "smart medical device" market. Will integrate Google Glass technology.
9. Exclusive rights to a new FDA 510k cleared medical device called the Muscle Pain Detection Device.
8. EPGL is extremely undervalued and with the significant technology value they possess should put them into the $8.00 range near term. More than $80.00 long term.
I`ll Leave it at that.. For Now.
Make sure you get started on your research
EPGL Website Click here
___________________________________________________________
EPGL: Technical Guidance
EPGL Made a HUGE Move back in early January 2013 And Traders have been taking full advantage of the swings ever since.
Don`t worry if you missed any of swings because it looks like we are about to
catch the biggest swing of them all.. Be Ready.
See for yourself: 6 Month Chart Click here
RSI is just under .50 and MACD is just a few trades away from a bullish cross
with plenty of room to the upside to take out the 52 week highs for good.
Make sure your in position before it happens!
Also, EPGL just filled the gap on a bounce off rock solid support which is exactly what traders have been waiting for before they get ready to go BIG.
It`s ok to go big as long as you keep those losses small, make sure your in
early and enter at or near support and resistance.
Take a closer look: EPGL 3 Month Click here
If any of our alerts fall below a % your not comfortable with..
Exit the trade and re-enter on support using the charts we provide.
That`s it.. for now.
Bookmark The Charts.. Trade Smart.. We will keep you
updated along the way.
